Neoleukin Therapeutics logo
Neoleukin Therapeutics NLTX
$ 3.49 0.0%

Quarterly report 2024-Q2
added 08-09-2024

report update icon

Neoleukin Therapeutics Income Statement 2011-2024 | NLTX

Annual Income Statement Neoleukin Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.72 M 37.6 M 142 M 682 M 318 M 52.7 M 305 M 333 M 133 M 92 M - - -

Shares

492 K 55.2 M 55 M 54.1 M 27 M 23.5 M 23.5 M 18.9 M 12.6 M 8.67 M - - -

Historical Prices

3.49 0.68 2.58 12 9.7 2.64 14.5 17.3 8.89 9.75 - - -

Net Income

13.7 M -55.2 M -60.7 M -33.3 M -69.4 M -31.6 M -50.2 M -37 M -21.9 M -24 M -8.73 M -7.71 M -

Revenue

- - - - - 25 M - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-55.6 M -56.5 M -60.7 M -33.7 M -71 M -32.6 M -51.1 M -37.6 M - - - - -

Interest Expense

12 K 2 K 19 K -44 K 1 K 4 K 4 K 1 K -520 K 462 K 42.9 K 9.47 K -

EBITDA

-52.3 M -53.3 M -59.4 M -47.6 M -22.9 M -31.5 M -50.2 M -37.1 M -21.7 M -22.2 M -9.68 M -7.53 M -

Operating Expenses

55.6 M 56.5 M 60.7 M 41.6 M 23.2 M 57.6 M 51.1 M 37.6 M 21.3 M 22.4 M - - -

General and Administrative Expenses

11.2 M 9.01 M 21.5 M 17.2 M 18.8 M 15.8 M 14.9 M 9.26 M 5.54 M 4.3 M 1.78 M 1.64 M -

All numbers in USD currency

Quarterly Income Statement Neoleukin Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

16.9 M 12.8 M 11.1 M 444 K 55.4 M 8.53 M 11.1 M 55.2 M 55.1 M 42.5 M 55.1 M 55 M 54.9 M 42.2 M 54.1 M 49.4 M 49.2 M 38 M 26.2 M 23.5 M 23.5 M 23.5 M 23.5 M 23.5 M 23.5 M 23.5 M 23.5 M 23.4 M 23.4 B 23.4 M 17.7 M 17.2 M 17.2 M 17.2 M 11.8 M 10.7 M 10.7 M 10.7 M 10.7 M 10.7 M 3.15 M 302 K 302 K 302 K 302 K - - - - - - - -

Net Income

-18.5 M - -4.53 M -11.9 M -14.2 M - -13.1 M -15.7 M -15.4 M - -15.4 M -15.1 M -15 M - -2.25 M -9.75 M -8.64 M - -59.1 M -1 K -2.21 M - -15 M 2.92 M -14.6 M - -11.8 M -13.8 M -8.32 M - -8.15 M -10.9 M -6.71 M - -5.04 M -4.75 M -6.41 M - -6.28 M -5.42 M -4.23 M - -3.37 M -812 K -1.01 M - - - - - - - -

Revenue

925 K - - - - - - - - - - - - - - - - - - - - - 25 M 25 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-20.1 M - -5.57 M -12.6 M -15.1 M - -13.6 M -15.9 M -15.4 M - -15.5 M -15.1 M -14.9 M - -2.25 M -9.77 M -9.07 M - -59.5 M -428 K - - -15.2 M 2.69 M - - -12.1 M -14 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - 1.04 M 981 K 945 K - 559 K 194 K 13 K - 6 K - - - - - - - -9 K - -1 K - -262 K -118 K -53 K - -7 K -9 K -20 K - -12 K 164 K 123 K - 4 K 5 K 6 K - 2 K 2 K 454 K - 1.64 K 1.77 K 1.83 K - - - - - - - -

EBITDA

-19.3 M - - -11.8 M -14.8 M - -12.4 M -15 M -15 M - -14.5 M -14.6 M -14.7 M - -1.67 M -9.38 M -8.9 M - -59.3 M -346 K 41 K - -15.2 M 2.69 M - - -12.1 M -14 M - - - - - - - - - - - 71.9 K 18.2 K - 45.2 K 15.6 K 14.8 K - - - - - - - -

Operating Expenses

21.1 M - 5.57 M 12.6 M 15.1 M - 13.6 M 15.9 M 15.4 M - 15.5 M 15.1 M - - - 9.77 M 9.07 M - 59.5 M 428 K 2.66 M - 15.2 M 22.3 M 14.8 M - 12.1 M 14 M 8.52 M - 8.28 M 11.1 M 6.83 M - 4.92 M 4.79 M 6.04 M - 6.31 M 5.63 M 2.62 M - 3.42 M 1.62 M 997 K - - - - - - - -

General and Administrative Expenses

5.32 M - 4.95 M 2.28 M 4.03 M - 4.14 M 4.92 M 4.66 M - 5.56 M 5.3 M 5.24 M - 3.86 M 4.93 M 3.57 M - 10.4 M 2.42 M 2.56 M - 4.48 M 4.31 M 4.31 M - 3.61 M 3.52 M 2.74 M - 2.15 M 1.83 M 1.95 M - 1.23 M 1.17 M 1.47 M - 987 K 1.08 M 735 K - 390 K 370 K 424 K - - - - - - - -

All numbers in USD currency